Overall, our study shows that prolonged treatment with a high dose of AEA contributes to the aggravation of SS hypertension and a consequent kidney injury, which in turn activates Nrf2-modulated TGF-β1/Smad3 pro-fibrotic signaling79,82. The gene discussed is TGFB1; the disease is Hypertension.